News Sentiment

TAK sentiment intelligence

Takeda Pharmaceutical Co Ltd ADR news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 38 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 16.56 Week of 10 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

95/100 classification confidence.

Company focus 38

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-1.3% over one week, +4.1% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Takeda Pharmaceutical (TAK) holder to resell 51,579 ADSs under Rule 144

Market Reaction

Balanced read

66/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 95/100 classification
One-week reaction -1.3% Price digesting
Trend fit Trend inactive 4.1% over four weeks
Fair value 16.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 29
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 38
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 27
Market source 4
Pharmaceutical Technology 1
GuruFocus 1
Pharma Voice 1
MT Newswires 1
Business Wire 1
Benzinga 1

Event Lens

What the news is about

Classified themes
Market update 38

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 38